St Jude Medical
STJ
STJ was delisted on the 4th of January, 2017.
1 hedge funds and large institutions have $6K invested in St Jude Medical in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
75% less funds holding
Funds holding: 4 → 1 (-3)
100% less capital invested
Capital invested by funds: $50.6M → $6K (-$50.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| 1 |
FPF
FNY Partners Fund
New York
|
-$50.3M |
| 2 |
JWA
JFS Wealth Advisors
Hermitage,
Pennsylvania
|
-$221K |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
-$46K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIM
1
Advantage Investment Management
Cedar Rapids,
Iowa
| $6K | – | – | – |
|
|
FPF
2
FNY Partners Fund
New York
| – | -$50.3M | -622,243 | Closed |
|
|
JWA
3
JFS Wealth Advisors
Hermitage,
Pennsylvania
| – | -$221K | -2,751 | Closed |
|
|
4
Envestnet Asset Management
Chicago,
Illinois
| – | -$46K | -562 | Closed |
|
STJ Hedge Fund Activity: Q2 2017 in Review
1 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q2 2017, worth a combined $6K — down 100% from $50.6M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of STJ and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was FNY Partners Fund, exiting entirely with an estimated $50.3M sold.
- 1 institutional investor held St Jude Medical (STJ) as of Q2 2017, down from 4 in Q1 2017.
- Funds reported $6K of St Jude Medical stock for Q2 2017, down 100% quarter-over-quarter.
- 0 funds opened new St Jude Medical positions in Q2 2017 and 3 closed out, a net change of -3 holders.
- The largest St Jude Medical seller in Q2 2017 was FNY Partners Fund, an estimated $50.3M sold.
Based on aggregated 13F filings for Q2 2017.